Assessing Prostate Cancer Screening
Health correspondent Susan Dentzer talks to doctors and patients about the debate over the merits of prostate cancer screening.
Transcript | RealAudio

Dr. Andrew von Eschenbach, director of the National Cancer Institute at the National Institutes of Health, talks to Susan Dentzer about his experience as
a prostate cancer patient and his research to assess and improve screening for the disease.

Dr. Edward Gelmann, a professor of oncology at Georgetown University School of Medicine is researching which men, if any, should be screened for prostate cancer using the prostate-specific antigen [PSA] test.

Dr. Patrick Walsh, director of the Jane Fucanon Brady Urological Institute at the Johns Hopkins Hospital, shares his thoughts on prostate cancer treatment and detection.

Prostate Cancer Test May Identify Dangerous Tumors
The PSA blood test used to screen for prostate cancer may predict how aggressively it will spread, according to a new study. (07/08/04)

National Cancer Institute
American Cancer Society
Consumer Reports' information on PSA testing
Association for the Cure of Cancer of the Prostate